Ana M. Molina
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Cancer Research top 1%
- Oncology top 2%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Robert J. MotzerDavid M. NanusScott T. TagawaThomas E. HutsonMartin H. VossM. Dror MichaelsonSujata PatilDarren R. Feldman
- Topics
- Prostate Cancer Treatment and Research (53 papers)Renal cell carcinoma treatment (52 papers)Radiopharmaceutical Chemistry and Applications (47 papers)
- Partner nations
- United StatesUnited KingdomIsrael
In The Last Decade
Ana M. Molina
123 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Pulmonary and Respiratory Medicine 2.5k
- Molecular Biology 1.7k
- Cancer Research 1.2k
- Oncology 1.2k
- Radiology, Nuclear Medicine and Imaging 513
Countries citing papers authored by Ana M. Molina
This map shows the geographic impact of Ana M. Molina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana M. Molina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana M. Molina more than expected).
Fields of papers citing papers by Ana M. Molina
This network shows the impact of papers produced by Ana M. Molina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana M. Molina. The network helps show where Ana M. Molina may publish in the future.
Co-authorship network of co-authors of Ana M. Molina
This figure shows the co-authorship network connecting the top 25 collaborators of Ana M. Molina. A scholar is included among the top collaborators of Ana M. Molina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana M. Molina. Ana M. Molina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 3 | |
| 4 | 6 | |
| 5 | 7 | |
| 6 | 4 | |
| 7 | 5 | |
| 8 | 0 | |
| 9 | 3 | |
| 10 | 27 | |
| 11 | 38 | |
| 12 | Clinical features of neuroendocrine prostate cancerbreakdown → | 232 |
| 13 | 6 | |
| 14 | 48 | |
| 15 | 33 | |
| 16 | 1 | |
| 17 | Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trialbreakdown → | 688 |
| 18 | 30 | |
| 19 | 27 | |
| 20 | 1 |
About Ana M. Molina
Ana M. Molina is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 129 papers that have together received 3.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (53 papers), Renal cell carcinoma treatment (52 papers) and Radiopharmaceutical Chemistry and Applications (47 papers). The work is most often cited by research in Cancer Research (1.2k citations), Pulmonary and Respiratory Medicine (2.5k citations) and Oncology (1.2k citations). Ana M. Molina has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include Robert J. Motzer, David M. Nanus, Scott T. Tagawa, Thomas E. Hutson, Martin H. Voss, M. Dror Michaelson, Sujata Patil, Darren R. Feldman, James Larkin and Karen Wood. Their work appears in journals such as Nature Genetics, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.